Litcius/Paper detail

Toll-like receptor-targeted nanoparticles: A powerful combination for tumor immunotherapy

Xin Zhi, Peipei Yang, Yunxue Xu, Zhifei Dai, Xiuli Yue, Linxue Qian

2023Nano Today14 citationsDOI

Topics & Concepts

ImmunotherapyImmune systemToll-like receptorCancer immunotherapyAgonistImmunologyNanocapsulesReceptorTumor microenvironmentMedicineCancer researchInnate immune systemNanotechnologyMaterials scienceInternal medicineNanoparticleImmunotherapy and Immune ResponsesNanoplatforms for cancer theranosticsImmune cells in cancer
Toll-like receptor-targeted nanoparticles: A powerful combination for tumor immunotherapy | Litcius